E Lavenne-Pardonge

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Propylene glycol-induced heparin resistance during nitroglycerin infusion

Jacques Col, C. Coldebeys, E Lavenne-Pardonge et al. · American Heart Journal · 1985 · 39 citations

Nitroglycerin Infusion, Medicine, Liver Physiology +8

Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects.

M Moriau, Luc Crasborn, E Lavenne-Pardonge et al. · PubMed · 1993 · 36 citations

Healthy Subjects, Pharmacotherapy, Platelet Aggregation +18

Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty

Claude Hanet, Michel F. Rousseau, Marie‐Françoise Vincent et al. · The American Journal of Cardiology · 1987 · 32 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Artery Disease +8

Liver transplantation and haemophilia A

Jan Lerut, Pierre‐François Laterre, E Lavenne-Pardonge et al. · Journal of Hepatology · 1995 · 26 citations

Transplantation Surgery, Transplantation, Hepatology +6